Prostate Cancer Market Research Study by Top Industry Players Profiles - OncoGenex Pharmaceuticals Inc., Bayer Pharma AG, Progenics Pharmaceuticals, Inc.

1
Prostate Cancer Market Research Report Forecast
to 2023
Global Industry Survey, Growth, Competitive
Landscapeand Forecasts to 2023
2
Prostate Cancer Market Research Report Forecast
to 2023
Prostate Cancer Market to Achieve Share worth USD
215 Billion By 2023
The global prostate cancer market is showing the
steady growth mainly owing to increase in
patient population. According to report published
by Centers for Disease Control and Prevention, in
2014, there were around 172,258 men in the United
States, who diagnosed with prostate cancer and
around 28,343 men died from prostate cancer.
These rising number of prostate cancer create an
opportunity for the player to introduce
innovative treatment option. Companies are
continuously invent new treatment to capture the
global market. Thus players invest more in
research and development activities. In this
regards, Bayer Pharma AG announced that they have
many drugs for the treatment of prostate cancer
in there pipeline such as Radium-223 dichloride
and BAY 1841788 (ODM-201, AR antagonist).
Browse Report Details _at_ https//www.marketresearch
future.com/reports/prostate-cancer-market-1580
3
Prostate Cancer Market Research Report Forecast
to 2023
Segmentation

• Global Prostate cancer market has been segmented
  on the basis of product type market is segmented
  into targeted therapies, therapeutic vaccines,
  hormone therapy and others. On the basis of end
  users market is segmented into hospitals,
  clinics and others.
• Request a Sample Report _at_ https//www.marketresear
  chfuture.com/sample_request/1580

4
Prostate Cancer Market Research Report Forecast
to 2023
Application Major Players in this Research
Market Prominent Players Some of the key
players in this market are OncoGenex
Pharmaceuticals Inc. (US), Bayer Pharma AG
(Berlin), Progenics Pharmaceuticals, Inc. (US),
TOLMAR Inc. (US), OncBioMune Pharmaceuticals Inc.
(US), Endo Pharmaceuticals Inc., Tokai
Pharmaceuticals, Inc. and others. Commenting on
the report, an analyst from Market Research
Future (MRFR)s team said The competitive
market is witnessing several strategies such as
mergers and collaborations that could take the
market forward. For instance, Illumina bought
Edico Genome, a data analysis company that
provides solutions for NGS. Myriad Genetics
acquired Counsyl, a specialist in carrier
screening and non-invasive prenatal
screening. Get Discount _at_ https//www.marketrese
archfuture.com/check-discount/1580
5
Prostate Cancer Market Research Report Forecast
to 2023
About Us Market Research Future At Market
Research Future (MRFR), we enable our customers
to unravel the complexity of various industries
through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and
Market Research Consulting Services. MRFR team
have supreme objective to provide the optimum
quality market research and intelligence services
to our clients. Our market research studies by
products, services, technologies, applications,
end users, and market players for global,
regional, and country level market segments,
enable our clients to see more, know more, and do
more, which help to answer all their most
important questions. In order to stay updated
with technology and work process of the industry,
MRFR often plans conducts meet with the
industry experts and industrial visits for its
research analyst members. For more information
kindly visit www.marketresearchfuture.com or
contact us at info_at_marketresearchfuture.com Copyri
ght 2018 Market Research Future All Rights
Reserved. This document contains highly
confidential information and is the sole property
of Market Research Future. No part of it may be
circulated, copied, quoted, or otherwise
reproduced without the written approval of Market
Research Future.
6
(No Transcript)